Further studies will be necessary to test for BMP6 responsive receptors on IFN-producing immune cells to see if ALK2/3 inhibitors alter their specific cytokine production profile in the context of Sjögren’s syndrome. Here, ACVR1 is linked to Sjogren syndrome.